BJ

Beijing Tong Ren Tang Chinese Medicine Co LtdOOTC BJTRF Stock Report

Last reporting period 31 Dec, 2023

Updated 11 Nov, 2024

Last price

Market cap $B

0.847

Micro

Exchange

OOTC - OTC

BJTRF Stock Analysis

BJ

Attractive

Based on Eyestock quantitative analysis, BJTRF`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

104/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

131.2 %

Undervalued

Market cap $B

0.847

Dividend yield

6.89 %

Shares outstanding

837.1 B

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.

View Section: Eyestock Rating